Alpine Woods Capital Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$14.1M |
| 2 |
Carter's
CRI
|
+$13.9M |
| 3 |
FedEx
FDX
|
+$13.8M |
| 4 |
Chevron
CVX
|
+$10.2M |
| 5 |
RTN
Raytheon Company
RTN
|
+$8.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.5M |
| 2 |
Meritage Homes
MTH
|
+$8.43M |
| 3 |
American Water Works
AWK
|
+$8.07M |
| 4 |
American Homes 4 Rent
AMH
|
+$7.83M |
| 5 |
Comcast
CMCSA
|
+$7.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 16.9% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 11.78% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.71% |
Similar funds
Alpine Woods Capital Investors's Q3 2014 Portfolio in Review
As of Q3 2014, Alpine Woods Capital Investors held 496 positions worth $1.88B, up 48,631% from $3.86M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Alpine Woods Capital Investors deployed $93.7M of net new capital in Q3 2014, opening 47 new positions and adding to 98 existing holdings. Its largest new stake was Carter's: 180,200 shares worth $14M.
By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $13.5M trimmed.
- Alpine Woods Capital Investors's largest Q3 2014 buy was Carter's: 180,200 shares worth $14M.
- Alpine Woods Capital Investors added most to Teva Pharmaceuticals in Q3 2014, an estimated $14.1M increase.
- Alpine Woods Capital Investors's biggest Q3 2014 reduction was Pfizer, cutting an estimated $13.5M.
- Alpine Woods Capital Investors fully exited Pier 1 Imports, Inc. in Q3 2014, selling an estimated $11.3K.
- Alpine Woods Capital Investors's ten largest holdings make up 17% of its $1.88B portfolio in Q3 2014.
- Alpine Woods Capital Investors opened 47 new positions and closed 38 in Q3 2014.
- Alpine Woods Capital Investors's portfolio value rose 48,631% quarter-over-quarter to $1.88B.
Based on Alpine Woods Capital Investors's 13F filing for Q3 2014, filed 12 Nov 2014.